A phase I study of TEV 90110 for the treatment of human immunodeficiency virus (HIV) infections

Trial Profile

A phase I study of TEV 90110 for the treatment of human immunodeficiency virus (HIV) infections

Planning
Phase of Trial: Phase I

Latest Information Update: 02 Dec 2014

At a glance

  • Drugs TEV 90110 (Primary)
  • Indications HIV infections
  • Focus Adverse reactions
  • Most Recent Events

    • 02 Dec 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top